EOSE vs. CRSP
EOSE (Eos Energy Enterprises Inc) and CRSP (CRISPR Therapeutics AG) are both stocks. EOSE operates in Electrical Equipment & Parts (Industrials), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, EOSE returned -13.16%/yr vs -13.88%/yr for CRSP. At a 0.29 correlation, their price movements are largely independent.
Performance
EOSE vs. CRSP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EOSE achieves a -17.80% return, which is significantly lower than CRSP's -0.80% return.
EOSE
- 1D
- 5.02%
- 1M
- 46.05%
- YTD
- -17.80%
- 6M
- -26.29%
- 1Y
- 126.99%
- 3Y*
- 57.09%
- 5Y*
- -13.16%
- 10Y*
- —
CRSP
- 1D
- -4.00%
- 1M
- 0.76%
- YTD
- -0.80%
- 6M
- 0.85%
- 1Y
- 40.78%
- 3Y*
- -7.16%
- 5Y*
- -13.88%
- 10Y*
- —
EOSE vs. CRSP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
EOSE Eos Energy Enterprises Inc | -17.80% | 135.80% | 345.87% | -26.35% | -80.32% | -63.92% | 114.85% |
CRSP CRISPR Therapeutics AG | -0.80% | 33.23% | -37.12% | 54.00% | -46.36% | -50.51% | 135.74% |
Correlation
The correlation between EOSE and CRSP is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2020 | 0.29 |
Fundamentals
EOSE:
$5.13B
CRSP:
$5.00B
EOSE:
-$1.45
CRSP:
-$6.24
EOSE:
19.27
CRSP:
1.15K
EOSE:
$160.71M
CRSP:
$4.10M
EOSE:
-$163.73M
CRSP:
-$171.17M
EOSE:
-$858.77M
CRSP:
-$509.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EOSE vs. CRSP — Risk / Return Rank
EOSE
CRSP
EOSE vs. CRSP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eos Energy Enterprises Inc (EOSE) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EOSE | CRSP | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.12 | 0.66 | +0.46 |
Sortino ratioReturn per unit of downside risk | 2.06 | 1.35 | +0.71 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.16 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 1.64 | 1.03 | +0.61 |
Martin ratioReturn relative to average drawdown | 3.33 | 1.75 | +1.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EOSE | CRSP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.12 | 0.66 | +0.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.11 | -0.23 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.00 | 0.23 | -0.23 |
Drawdowns
EOSE vs. CRSP - Drawdown Comparison
The maximum EOSE drawdown since its inception was -97.88%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for EOSE and CRSP.
Loading charts...
Drawdown Indicators
| EOSE | CRSP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.88% | -85.11% | -12.77% |
Max Drawdown (1Y)Largest decline over 1 year | -77.10% | -42.25% | -34.85% |
Max Drawdown (3Y)Largest decline over 3 years | -87.18% | -64.91% | -22.27% |
Max Drawdown (5Y)Largest decline over 5 years | -96.94% | -80.68% | -16.26% |
Current DrawdownCurrent decline from peak | -69.05% | -75.23% | +6.18% |
Average DrawdownAverage peak-to-trough decline | -72.39% | -49.16% | -23.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.96% | 24.84% | +13.12% |
Volatility
EOSE vs. CRSP - Volatility Comparison
Eos Energy Enterprises Inc (EOSE) has a higher volatility of 33.77% compared to CRISPR Therapeutics AG (CRSP) at 15.39%. This indicates that EOSE's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EOSE | CRSP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 33.77% | 15.39% | +18.38% |
Volatility (6M)Calculated over the trailing 6-month period | 91.83% | 42.57% | +49.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 113.81% | 61.70% | +52.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.89% | 60.49% | +56.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 112.93% | 64.29% | +48.64% |
Dividends
EOSE vs. CRSP - Dividend Comparison
Neither EOSE nor CRSP has paid dividends to shareholders.
Financials
EOSE vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between Eos Energy Enterprises Inc and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EOSE and CRSP have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EOSE has higher volatility (33.77%) compared to CRSP (15.39%). In terms of maximum drawdown, EOSE dropped -97.88% vs CRSP's -85.11%.
EOSE currently has the higher Sharpe Ratio (1.12 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EOSE and CRSP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer